nivolumab,relatlimab
bms
['nivolumab', 'relatlimab', 'nivo', 'ca,022,1', 'ca,022,i', 'imab ', 'bms', 'bmsnews']
some other considerations from dr marc theoret / breaking down some points in the trial supporting combination #cancer #immunotherapy with #relatlimab #lag3 + anti-pd-1 #nivolumab #sitc2022 / #sitc22 pre-meeting 